What is he best known for?
The fields of study he is best known for:
- Gene
- Immune system
- Cytokine
Immunology, Interleukin 21, Interleukin 12, Immune system and Lymphokine-activated killer cell are his primary areas of study.
His Immunology study integrates concerns from other disciplines, such as Natural killer cell and Liver injury.
His research integrates issues of Natural killer T cell, Cell, IL-2 receptor and Innate lymphoid cell in his study of Interleukin 21.
He has researched Interleukin 12 in several fields, including Cancer research, Cellular differentiation and Cell biology.
The concepts of his Immune system study are interwoven with issues in Immunophenotyping, Flow cytometry and Lung.
His work in Lymphokine-activated killer cell addresses issues such as Acquired immune system, which are connected to fields such as TIGIT.
His most cited work include:
- Functional exhaustion of antiviral lymphocytes in COVID-19 patients. (646 citations)
- Liver : An Organ with Predominant Innate Immunity (583 citations)
- Dopamine Controls Systemic Inflammation through Inhibition of NLRP3 Inflammasome (454 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Immunology, Immune system, Interleukin 21, Cancer research and Cell biology.
The Immunology study which covers Natural killer cell that intersects with NKG2D.
His Immune system research includes elements of Inflammation, Virus, Lymphatic system and Cytokine.
His Interleukin 21 study incorporates themes from Interleukin 12 and IL-2 receptor.
His research investigates the link between Cancer research and topics such as Cell that cross with problems in Cell growth and Effector.
His Cell biology research includes themes of Phenotype, Receptor, Cell culture and Cytolysis.
He most often published in these fields:
- Immunology (76.89%)
- Immune system (37.80%)
- Interleukin 21 (34.34%)
What were the highlights of his more recent work (between 2016-2021)?
- Immunology (76.89%)
- Cancer research (30.89%)
- Immune system (37.80%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Immunology, Cancer research, Immune system, Cell and Cell biology.
His study in Innate immune system, Acquired immune system, Immunity, Interleukin 21 and Inflammation falls under the purview of Immunology.
His work carried out in the field of Cancer research brings together such families of science as Natural killer cell, Adoptive cell transfer and TIGIT, Immunotherapy.
Zhigang Tian has included themes like Gut flora and Lymphatic system in his Immune system study.
His Cell research also works with subjects such as
- Effector, which have a strong connection to Tumor progression,
- Homeostasis most often made with reference to T cell.
In his study, which falls under the umbrella issue of Cell biology, Antigen, Hepatic stellate cell and Major histocompatibility complex is strongly linked to Receptor.
Between 2016 and 2021, his most popular works were:
- Functional exhaustion of antiviral lymphocytes in COVID-19 patients. (646 citations)
- Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients (409 citations)
- Guidelines for the use of flow cytometry and cell sorting in immunological studies (301 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Immune system
- Cancer
His scientific interests lie mostly in Immunology, Immune system, Cell, Cancer research and Lymphokine-activated killer cell.
His research brings together the fields of Homeostasis and Immunology.
His Immune system research incorporates elements of Immunophenotyping, Computational biology, Immunologic Technique and Mass cytometry.
His Cell research integrates issues from Cancer, Immunity, Receptor, Effector and Mitochondrial fission.
His study looks at the relationship between Cancer research and fields such as TIGIT, as well as how they intersect with chemical problems.
His Lymphokine-activated killer cell research is multidisciplinary, relying on both Natural killer T cell and Cancer immunotherapy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
